WT1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of WT1 monoclonal antibodies for various research applications. WT1 monoclonal antibodies are optimized for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). WT1, or Wilms' Tumor 1, is a transcription factor that plays a vital role in kidney and organ development, while also regulating cell growth and differentiation. Research has shown that WT1 expression patterns are frequently altered in various cancer types, establishing WT1 as a significant biomarker in oncology research. Scientists studying WT1 have uncovered its importance in cellular development and disease progression. Ongoing research continues to reveal new functions and regulatory mechanisms of WT1 in both normal and pathological conditions. Understanding WT1's molecular mechanisms has opened new avenues for therapeutic development. The extensive selection of WT1 monoclonal antibodies from Santa Cruz Biotechnology enables researchers worldwide to advance scientific understanding and potentially develop new therapeutic strategies for cancer treatment.